As part of the continuous assessment and improvement process associated with accreditation of the Biomedical Engineering Program by the Accreditation Board for Engineering and Technology (ABET), faculty within the program have undertaken a comprehensive review and revision of the undergraduate curriculum and approved (September 28, 2016) several course changes. These changes, which are based upon input from senior course reviews and exit interviews, include modifications to the sequencing of coursework, course pre- and co-requisites, learning outcomes, and course descriptions.
Specifically for BMEN 391, the pre-requisites have been changed to reflect the connection of this course to new courses that have been added to the curriculum. The pre-requisite CHEM 333 has been replaced by CHEM 550/BIOL 541. CHEM 550/BIOL 541 has been added as a requirement within the new curriculum to enhance student knowledge of biochemistry, which will better prepare students for BMEN 391. Currently, CHEM 333 is listed as an alternate to this pre-requisite to allow current students, who remain in the prior curriculum, to continue to matriculate through the pre-requisites. The CHEM 333 pre-requisite option will be removed when those students have graduated. In addition, a C or better progression has been added for the pre-requisite of BMEN 290, a change included to increase the checks and balances since the 'Upper Division' checkpoint has been removed from the program (part of a college-wide effort to streamline and coordinate program progression requirements across the college).
In addition, the course catalog description has been modified to omit basic kinetic concepts and genetic engineering. These changes are motivated, respectively, by the background that students will receive in the new course, BMEN 240 (a pre-requisite for BMEN 290), and the experience that genetic engineering does not integrate well within the course topics.